Fairvalue-Calculator Fairvalue-Calculator
EN DE

Johnson Chemical Pharmaceutical Works Co (4747) Fair Value & Analysis

Healthcare · TW · Market cap 2.5B TWD

Price52.80 TWD
Fair Value38.70 TWD
Upside-26.7%
Quality95/100
Evidence: High Range 31.49 TWD – 48.15 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Johnson Chemical Pharmaceutical Works Co (4747) currently trades at 52.80 TWD, while our model-based Fair Value estimate is 38.70 TWD — implying the stock looks roughly 26.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Johnson Chemical Pharmaceutical Works Co (4747) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 38.70 TWD versus a price of 52.80 TWD — about −27% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 4747?
Our 21-model fair value for Johnson Chemical Pharmaceutical Works Co is 38.70 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 52.80 TWD.
What is the quality score of 4747?
Johnson Chemical Pharmaceutical Works Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.